Neorocritical care centres could save lives
10 May 2005
The lives of tens of thousands of people with brain injuries could be saved, with a better quality recovery, at less cost, through the introduction of specialised neurocritical care centres, according to a leading British anaesthetist.
There is now clear evidence that such specialist centres could significantly improve the quality of survival, Professor David Menon said in Auckland today.
Neurocritical care is intensive or critical care of patients whose primary problem is in the nervous system, most commonly the brain. Common causes of such disease include head trauma, stroke, brain haemorrhage, meningitis, and diseases of the nerves and muscles.
Professor Menon, Professor of Anaesthesia at Cambridge University, was speaking at the Annual Scientific Meeting (ASM) of the Australian and New Zealand College of Anaesthetists (ANZCA), being attended by 1,000 anaesthetists, intensivists and pain medicine specialists from around the world. The theme of the meeting is "Improving Outcomes".
He said that research in recent years had increasingly demonstrated the efficacy of specialist neurocritical treatment, particularly in the field of acute brain injury.
Standard guidelines had been developed by several expert bodies in the late 1990s, after an assessment of the various treatment options then in use.
The US Brain Trauma Foundation had later estimated that, based on these guidelines, 20,000 lives could be saved each year in the USA alone, and clear benefits had been demonstrated since under protocols broadly based on the American guidelines.
"More recently (2002/03) there have
been numerous reports of significant improvements in outcome
from evidence based management of severe head injury,
compared with historical controls," Professor Menon
said.
"According to two relevant studies, there were
clear improvements in the proportion of patients
experiencing favourable outcomes - from 40.4 per cent to
59.6 per cent in severe head injury, and from 40 per cent to
84 per cent in all head injured patients.
"These data
suggest that good quality neurocritical care has its most
consistent impact not on survival but on the more desirable
goal of quality of survival.
"It is also clear that these
results are best achieved by professional intensivists,"
Professor Menon said.
Arguments for neurocritical specialisation included the fact that clinical teams who frequently cared for patients with acute brain injury were more likely to have knowledge of secondary damage, and would better understand the pathophysiology they treat. As well, specialisation often attracted greater volumes of patients and a greater case-load was very likely to improve expertise in the area, as it did in others.
While the examples listed above referred to specialist stand-alone neurocritical care units, it was entirely possible for high quality neurocritical care to be delivered in some dedicated "general" intensive care units.
"Neurocritical care is not
a label - it is a way of life which recognises the special
needs of the acutely ill neurological patient and uses the
available knowledge to maximise outcomes in this group,"
Professor Menon said.
"The availability of high quality
intensive care in this context is an investment that pays
for itself many times over in improved outcome and reduced
costs for rehabilitation and support services during the
later stages of the illness.
"For example, good intensive
care can mean the difference between a head injured teenager
being dead or alive, bed-bound or mobile in a wheelchair,
and suffering from severe learning difficulties or leading a
near normal life," he said.
Professor Menon said there already were a number of specialised neurocritical care units in the USA, the UK and Europe that concentrated on brain and associated injury or illness.
ENDS